Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin
Clinical trial NCT01466504 · TERMINATED
Trial details
- NCT number
- NCT01466504
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2011-05-01
- Primary completion
- 2013-04-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.